Trastuzumab deruxtecan yields promising results in HER2-positive breast cancer patients pretreated with TDM-1

Bookmark and Share
Published: 18 Dec 2019
Views: 4005
Dr Ian Krop - Dana Farber Cancer Institute, Boston, USA

Dr Ian Krop gives a press conference at the 2019 San Antonio Breast Cancer Symposium about the latest results from the DENSITY-Breast01 study.

Watch our interview with Dr Krop here.

Read more about the study here